Zobrazeno 1 - 10
of 33
pro vyhledávání: '"WangLai Hu"'
Autor:
Zhen Lei, Zhipu Zhu, Zhihui Yao, Xiangyu Dai, Yi Dong, Bing Chen, Songyu Wang, Siyue Wang, Lutterodt Bentum-Ennin, Lei Jin, Hao Gu, Wanglai Hu
Publikováno v:
Cell Death and Disease, Vol 15, Iss 7, Pp 1-9 (2024)
Abstract Proto-oncogenic MYC is frequently dysregulated in colorectal cancer (CRC). In the past decades, long noncoding RNAs (lncRNAs) have emerged as important regulators in cancers, acting as scaffolds, molecular decoys, post-transcriptional regula
Externí odkaz:
https://doaj.org/article/76995218685f4f0fb00720b8b1bca5b7
Autor:
Zhipeng Yin, Hao Li, Heng Zhao, Lutterodt Bentum-Ennin, Yang Xia, Zaibiao Wang, Wanglai Hu, Hao Gu, Shangxin Zhang, Guangyun Li
Publikováno v:
Heliyon, Vol 10, Iss 16, Pp e36133- (2024)
Mutations in oncogenes such as KRAS, NRAS and BRAF promote the growth and survival of tumors, while excessive RAS/RAF/MEK/ERK activation inhibits tumor growth. In this study we examined the precise regulatory machinery that maintains a moderate RAS/R
Externí odkaz:
https://doaj.org/article/69ff5dcf4ee74a8e89a5dd7ee6cb91a7
Autor:
Shuang Wu, Xiangyu Dai, Zhipu Zhu, Dianhui Fan, Su Jiang, Yi Dong, Bing Chen, Qi Xie, Zhihui Yao, Qun Li, Rick Francis Thorne, Yao Lu, Hao Gu, Wanglai Hu
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 49, Iss , Pp 100971- (2024)
More than half of all cancers demonstrate aberrant c-Myc expression, making this arguably the most important human oncogene. Deregulated long non-coding RNAs (lncRNAs) are also commonly implicated in tumorigenesis, and some limited examples have been
Externí odkaz:
https://doaj.org/article/e594d899c9254c1e8b740f3363cfd418
Autor:
Hao Gu, Yang Xia, Lili Guo, Zifei Wang, Shuang Wu, Yuan Xu, Yaqin Zhang, Jing Huang, Yu Lei, Wanglai Hu
Publikováno v:
Cancer Communications, Vol 40, Iss 9, Pp 456-460 (2020)
Externí odkaz:
https://doaj.org/article/c52fc18213474f4dae2a95454624b467
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-8 (2017)
Abstract Reprogramming of adult somatic cells into induced pluripotent stem cells holds great promise in clinical therapy. Increasing evidences have shown that p53 and its target genes play important roles in somatic cell reprogramming. In this study
Externí odkaz:
https://doaj.org/article/46b8c69175644bd1a57a0477d1d5901d
Autor:
Lili Guo, Yang Xia, Hao Li, Zifei Wang, Hui Xu, Xiangyu Dai, Yaqin Zhang, Hao Zhang, Wenhu Fan, Feng Wei, Qun Li, Ling Zhang, Limian Cao, Shangxin Zhang, Wanglai Hu, Hao Gu
Publikováno v:
Cancer Gene Therapy.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eafed035bda9910cc9dd82a0b2cf9b09
https://doi.org/10.1038/s41417-023-00624-z
https://doi.org/10.1038/s41417-023-00624-z
Autor:
Yang Xia, Wanglai Hu, Qun Li, Bing Chen, Yuan Xu, Lili Guo, Yaqin Zhang, Qi Xie, Jing Huang, Yi Dong, Shuang Wu, Hao Gu
Publikováno v:
Journal of Cancer
Colorectal cancer (CRC) is still one of the leading causes of cancer-associated death in the modern society. The biological function of miR-202-5p for CRC development remains controversial, largely due to the fact that miR-202-5p can be tumor-suppres
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::171becdf1ab0f22a4df9745cdcaef215
https://doi.org/10.7150/jca.56186
https://doi.org/10.7150/jca.56186
Autor:
Qiuyan Wang, Jin Wu, Xiaoliang Xu, Daheng Jiang, Wanglai Hu, Changqiu Ma, Shuhui Wang, Lixin Zhu, Yuanjin Li
Publikováno v:
RSC Advances. 11:12682-12686
Photocatalytic organic synthesis is mostly limited by the shortcomings of insufficient light absorption, high photogenerated electron–hole recombination rate and inadequate reactive sites of photocatalysts. To solve these problems, phosphorus-doped
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c27772284104a9771f15b389a3c2a06
https://doi.org/10.1039/d1ra00701g
https://doi.org/10.1039/d1ra00701g
Autor:
Mingmeng Fang, Hui Jiang, Dongyao Wang, Xuhan Zhang, Baolin Tang, Xiaoyu Zhu, Wanglai Hu, Xin Liu, Anyou Wang
Publikováno v:
Biomedicinepharmacotherapy = Biomedecinepharmacotherapie. 153
Around 70 % of patients diagnosed with acute myeloid leukemia (AML) survive less than 5 years due to drug resistance and disease relapse. Consequently, improved clinical treatments are urgently needed. Some but not all AML patients benefit from the c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4eb092af190323077da2082f545d6249
https://pubmed.ncbi.nlm.nih.gov/36076608
https://pubmed.ncbi.nlm.nih.gov/36076608
Autor:
Zifei Wang, Yuan Xu, Jing Huang, Yaqin Zhang, Hao Gu, Shuang Wu, Wanglai Hu, Yang Xia, Yu Lei, Lili Guo
Publikováno v:
Cancer Communications, Vol 40, Iss 9, Pp 456-460 (2020)
Cancer Communications
Cancer Communications
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19174b566d5e53abe5657ba5e9802b19
https://doi.org/10.1002/cac2.12079
https://doi.org/10.1002/cac2.12079